Literature DB >> 19813682

Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad.

Bikha Ram Devrajani1, Syed Zulfiquar Ali Shah, Tarachand Devrajani, Dileep Kumar.   

Abstract

OBJECTIVE: To determine the precipitating factors of hepatic encephalopathy (HE) in patients with liver cirrhosis at Liaquat University Hospital Hyderabad/Jamshoro.
METHODS: This hospital based descriptive study was conducted from April 2007 to September 2007. All the patients who were more than 12 years of age and were diagnosed as hepatic encephalopathy were studied. During this period, 87 patients of hepatic encephalopathy were admitted. All patients were carefully examined, relevant investigations were performed and data was collected through pre-designed proforma.
RESULTS: Male patients were 65 (75%), above 40 years of age 58 (67%), belonging to interior/periphery of Sindh 54 (62%), in grade IV of hepatic encephalopathy 70 (80%) and Anti-HCV positive were 52 (60%). The most common precipitating factors detected were infection 58 (67%), constipation 43 (49%) and gastrointestinal bleeding 39 (45%). Out of 87 patients, 68 had increased total leucocytes count, 09 patients had hypokalaemia, 24 patients, hyponatraemia, 64 hypoalbuminaemia and 54 patients had a disturbed coagulation profile. Fifty nine patients recovered and were discharged while 20 patients expired. Majority of expired patients had Child-Pugh score 10-15 and were in grade IV of hepatic encephalopathy.
CONCLUSION: The study concluded that there were different factors which play a key role in hepatic encephalopathy. In these factors, infection was the most common.

Entities:  

Mesh:

Year:  2009        PMID: 19813682

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  9 in total

1.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

2.  Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience.

Authors:  Pei-Chang Lee; Ying-Ying Yang; Ming-Wei Lin; Ming-Chih Hou; Chien-Sheng Huang; Kuei-Chuan Lee; Ying-Wen Wang; Yun-Cheng Hsieh; Yi-Hsiang Huang; Chi-Jen Chu; Han-Chieh Lin
Journal:  Dig Dis Sci       Date:  2014-01-31       Impact factor: 3.199

Review 3.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Kuo-Chih Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

5.  Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis.

Authors:  Nandu S Poudyal; Sitaram Chaudhary; Sudhamshu Kc; Bidhan N Paudel; Bhupendra K Basnet; Amrendra Mandal; Paritosh Kafle; Baikuntha Chaulagai; Azad Mojahedi; Mukesh S Paudel; Barun Shrestha; Vijay Gayam
Journal:  Cureus       Date:  2019-04-02

Review 6.  Lights and Shadows in Hepatic Encephalopathy Diagnosis.

Authors:  Piero Amodio; Sara Montagnese
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

Review 7.  Inadequate practices for hepatic encephalopathy management in the inpatient setting.

Authors:  Jawaid Shaw; Lisa Beyers; Jasmohan S Bajaj
Journal:  J Hosp Med       Date:  2022-08       Impact factor: 2.899

8.  A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy.

Authors:  Qiu-Ming Wang; Qing Ji; Zhi-Jun Duan; Ming Zhang; Qing-Yong Chang
Journal:  Exp Ther Med       Date:  2013-06-03       Impact factor: 2.447

9.  Acute Changes in Mentation in a Patient with Hepatic Cirrhosis Treated with High Doses of Dexamethasone.

Authors:  Luis Dabul; Andrew Droney; Juan Oms; Marcos A Sanchez-Gonzalez
Journal:  Cureus       Date:  2017-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.